MetLife announced on August 5, 2026 a $3 billion equity buyback program. The authorization allows the company to repurchase its own shares up to that dollar limit — no shares have necessarily been bought yet.
For holders, a buyback reduces the share count over time, meaning each remaining share represents a larger slice of the company. For short sellers, the picture is relatively calm: short interest sits at 2.4% of free float, with a cost to borrow of just 0.46% and availability remaining loose. A buyback can reduce the pool of shares in the market, but with days-to-cover at 3.5, the short side faces no immediate pressure.
Across 299 comparable buyback announcements in the broader market, shares moved an average of 1.4% over the following five trading days, with 62.5% moving in a positive direction.
See the live data behind this article on ORTEX.
Open MET on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
